XP Chemistries ABOMXSTO: XPC

XPC: Q3 2024 saw lower sales, improved losses, and a regulatory delay for XP Chemistries

· Issued by XP Chemistries AB

XP Chemistries reported lower sales and losses for Q3 2024 but improved operating results year-over-year. Regulatory approval for its capsaicin feed additive is delayed to early 2025, with new financing secured through warrant exercises.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

XP Chemistries AB on 6ix

Earlier from XP Chemistries

Later from XP Chemistries

All XP Chemistries news releases